Stephen Mahoney
2017 - Kiniksa Pharmaceuticals, Ltd.
In 2017, Stephen Mahoney earned a total compensation of $716.4K as President and Chief Operating Officer at Kiniksa Pharmaceuticals, Ltd..
Compensation breakdown
| Non-Equity Incentive Plan | $81,000 |
|---|---|
| Option Awards | $219,629 |
| Salary | $405,000 |
| Other | $10,800 |
| Total | $716,429 |
Mahoney received $405K in salary, accounting for 57% of the total pay in 2017.
Mahoney also received $81K in non-equity incentive plan, $219.6K in option awards and $10.8K in other compensation.
Rankings
In 2017, Stephen Mahoney's compensation ranked 10,498th out of 14,666 executives tracked by ExecPay. In other words, Mahoney earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,498 out of 14,666 | 28th |
Division Manufacturing | 4,078 out of 5,772 | 29th |
Major group Chemicals And Allied Products | 1,446 out of 2,075 | 30th |
Industry group Drugs | 1,179 out of 1,731 | 32nd |
Industry Pharmaceutical Preparations | 918 out of 1,333 | 31st |
Source: SEC filing on April 17, 2019.
Mahoney's colleagues
We found two more compensation records of executives who worked with Stephen Mahoney at Kiniksa Pharmaceuticals, Ltd. in 2017.
News
Signal Genetics CEO Scott Myers receives $36M in 2023
April 26, 2024
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2019 pay falls 35% to $4.8M
April 28, 2020
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2018 pay jumps 389% to $7.3M
April 17, 2019